Score Breakdown
Dilution Forecast
Market Data
Source-Backed Evidence Depth
This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.
| Field | Current Value | Basis |
|---|---|---|
| DilutionScore | 22/100 | DilutionWatch score record |
| Shares Outstanding | 255.54M | Verified float table or market cache |
| Public Float | 220.86M | Verified float table or market cache |
| Market Cap | $2.04B | Market data cache |
| Cash Runway | 22.2 months | DilutionWatch score inputs |
| Shelf Capacity | None in current score inputs | SEC-derived dilution fields |
| ATM Capacity | None in current score inputs | SEC-derived dilution fields |
| Outstanding Warrants | None in current score inputs | SEC-derived dilution fields |
Recent source-backed SEC insight records available on this page: 5.
Recent SEC source mix: 4 5.
The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.
BCRX SEC Filing Activity — Last 12 Months
Shares outstanding reported by BCRX on the cover page of its latest 10-K/10-Q: 255.54M as of July 31, 2026.
DilutionWatch recorded 1 registration or prospectus document for BCRX (the filings through which shares are offered) in the last 12 months. Full filing list on SEC EDGAR →
| Form | What it is | Filings | Most recent |
|---|---|---|---|
| 424B3 | prospectus (resale / ATM) | 1 | Dec 18, 2025 |
| EFFECT | SEC declared a registration effective | 1 | Dec 18, 2025 |
| 8-K | current report (material event) | 14 | Aug 05, 2026 |
| SC 13G | passive >5% holder filing | 1 | Aug 07, 2026 |
| 4 | insider transaction | 11 | Sep 02, 2026 |
| 3 | initial insider ownership | 3 | May 12, 2026 |
Institutional Holdings
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Recent SEC Activity
Recent News
Factual BCRX Dilution Snapshot
BioCryst Pharmaceuticals, Inc. (BCRX) has a DilutionScore of 22/100, rated Low dilution risk. Score date: October 27, 2026.
- Recent SEC activity tracked for BCRX: 4 on 2026-09-02; 4 on 2026-09-02; 4 on 2026-09-02.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
DilutionScore History — Last 90 Days
BCRX's DilutionScore is currently 22/100 (Low risk), with 6 score changes tracked over 89 days. The score deteriorated from 34/100 (Medium risk).
| Period | Score | Risk Level | Duration |
|---|---|---|---|
| Oct 26 – Oct 27, 2026 | 22/100 | LOW | 2 days |
| Oct 22 – Oct 25, 2026 | 34/100 | MEDIUM | 4 days |
| Oct 21, 2026 | 22/100 | LOW | 1 day |
| Oct 17 – Oct 20, 2026 | 34/100 | MEDIUM | 4 days |
| Aug 22 – Oct 16, 2026 | 22/100 | LOW | 56 days |
| Aug 14 – Aug 21, 2026 | 26/100 | MEDIUM | 7 days |
| Jul 30 – Aug 13, 2026 | 27/100 | MEDIUM | 15 days |
Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.
Share Dilution History
BCRX shares outstanding have increased 2.5% from 248.04M (Mar 2026) to 254.16M (May 2026). Each increase represents potential dilution to existing shareholders.
| Date | Shares Outstanding | Public Float | Change |
|---|---|---|---|
| May 18, 2026 | 254.16M | 220.85M | ▼ 0.31% |
| May 10, 2026 | 254.16M | 221.54M | ▲ 0.06% |
| May 09, 2026 | 254.16M | 221.41M | ▲ 1.28% |
| May 03, 2026 | 254.11M | 218.61M | ▲ 0.19% |
| Mar 05, 2026 | 248.04M | 218.19M | ▲ 0.03% |
Share counts sourced from verified regulatory filings. Increases indicate dilution events.
Related Stocks — LOW Risk
Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.